Classical CD14+CCR2+ monocytes infiltrate neoplasms and contribute to the majority of myeloid cells within the tumor microenvironment (8, 9), but they are eventually reprogrammed into pro-tumoral monocyte-derived cells by the cancer niche (10). This evidence concerns the gene CCR2 and neoplasm.